Oragenics Inc. (OGEN) Fundamentals

Oragenics Inc is engaged in the healthcare sector. The firm is focused on becoming a leader in developing novel antibiotics against infectious diseases and on developing effective treatments for oral mucositis. Oragenics involves developing its antibiotic product candidate, OG716 as well as other homolog antibiotic product candidates, researching LBPs, and having other product candidates, including SMaRT Replacement Therapy positioned for out-licensing or partnering. It is also developing a Terra CoV-2 immunization product candidate to combat the novel coronavirus.
SHARE INFORMATION
Market CapUS$ 13 786 090
Shares Outstanding1 961 037
Float1 908 424
Percent Float97,32%
Short Interest0,00
Short Percent Float0,0%
Short Interest Ratio0,00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0,00
Latest Fiscal RevenueUS$ 86 987
Latest Fiscal EPSUS$ -8,40
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0,00
Dividend (5 Years)US$ 0,00
Ex Dividend Date-
Dividend RateUS$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions51
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months106 702
Institutional Holdings Percent20,6%
Institutional Sold Previous 3 Months764 750
Insider Holdings Date2023-01-31
Insider Bought Previous 3 Months-
Insider Holdings Percent6,2
Insider Sold Previous 3 Months710 836
Insider Shares Owned7 254 634
TRADING INFO
52 Week HighUS$ 26,40
52 Week LowUS$ 6,04
52 Week High ChangeUS$ -73,03
21 Day Moving AverageUS$ 7,3736
21 Day Extended Moving AverageUS$ 7,3509
50 Day Moving AverageUS$ 8,7847
50 Day Extended Moving AverageUS$ 8,6852
200 Day Moving AverageUS$ 15,2855
200 Day Extended Moving AverageUS$ 15,1543
10 Day Average Volume25 053
20 Day Average Volume35 360
30 Day Average Volume34 214
50 Day Average Volume25 379
Alpha-0.006043
Beta0.3982
Standard Deviation0.351286
R20.003749
7 Day Price ChangeUS$ 0,43
7 Day Percent Change6,52%
21 Day Price ChangeUS$ -1,49
21 Day Percent Change-17,49%
30 Day Price ChangeUS$ -1,31
30 Day Percent Change-15,71%
Month to Date Price ChangeUS$ 0,43
Month to Date Percent Change6,52%
Quarter to Date Price ChangeUS$ 0,724
Quarter to Date Percent Change11,48%
180 Day Price ChangeUS$ -15,17
180 Day Percent Change-68,33%
200 Day Price ChangeUS$ -13,21
200 Day Percent Change-65,27%
Year to Date Price ChangeUS$ 0,724
Year to Date Percent Change11,48%

Oragenics Inc. (OGEN) Key Ratios

PROFITABILITY
EBIT Margin-18 696,9%
EBITDA Margin-18 653,2%
Pre-Tax Profit Margin0,0%
Profit Margin Count0,0%
Gross Margin0,0%
Profit Margin TOT0,0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0,00
Revenue (3 Years)US$ 0,00
Revenue (5 Years)US$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book1,20
Total Debt To Equity0,10
Int Coverage-1 130,10
Current Ratio9,70
Leverage Ratio1,30
Quick Ratio9,30
Long Term Debt To Capital0,02
VALUATION MEASURES
PE Ratio-0,90
Enterprise ValueUS$ 2 886 780
Price to Sales0,00
Price to Free Cash-1,10
PE High Last 5 Years-1,20
Price To Book1,20
Price To Cash Flow0,00
PE Low Last 5 Years-1,30
Price to Tangible Book1,20
MANAGEMENT EFFECTIVENESS
Receivables Turnover0,00
Invoice Turnover0,00
Assets Turnover0,00
Return Assets-70,57
Return on Equity-86,51
Return on Capital-82,79

Oragenics Inc. (OGEN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorMayer Hoffman McCann P.C.
CEOKimberly M. Murphy
Emplyoees5
Last AuditUE
CIK0001174940
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address4902 Eisenhower Boulevard
Suite 125
Tampa, FL 33634
Websitehttps://www.oragenics.com
Facsimile+1 813 286-7904
Telephone+1 813 286-7900
Emailjohnm@coreir.com
Dernières Valeurs Consultées
AMEX
OGEN
Oragenics
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

Se connecter à ADVFN
S'inscrire maintenant
Les cours EURONEXT (CAC 40, etc. ) et FOREX (les devises) sont en direct si connecté.
NYSE, AMEX, et ASX sont en différé d'environ 20 minutes. Les autres cours sont en différé d'environ 15 minutes.

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

P: V:fr D:20230209 13:32:34